April 2026: The White House signed an executive order directing $50M into federal psychedelic research — with ibogaine at the center. The science is now policy. This guide was written for exactly this moment.
An 83-page evidence-based guide to ibogaine, psilocybin, MDMA, and ketamine — written by a board-certified clinician with no agenda, no ideology, and no hype.
Most of what reaches the public strips out the nuance, the methodology, and the caveats that actually matter. This guide exists to fix that.
Stanford research showed 88% reduction in PTSD symptoms after a single ibogaine session in Special Operations veterans. This guide explains what that means and what to do with it.
If you've tried multiple antidepressants or years of therapy without adequate relief — this guide maps what else exists, how to access it legally, and what to expect.
You're not sure what to believe. Media either hypes or dismisses this research. This guide cites primary sources and tells you exactly what the science does and doesn't say.
A readable synthesis of the current evidence base — written in plain language without sacrificing clinical accuracy. Understand what your patients are researching.
From the neuroscience of how these substances work to what treatment actually looks like day-to-day.
The ebook tells you what the science says. The bonuses tell you what to do next.
Section-by-section checklists for vetting ketamine clinics, psilocybin facilitators, ibogaine retreats, and MDMA trials. Includes 8 universal red flags and a quick-reference resource directory.
Guided journal prompts for before, during, and after your session. 4 weeks of integration check-ins designed for the neuroplasticity window. Printable and built for actual use.
Legal international programs, screening criteria, cost assistance, VA navigation, and what to expect clinically. Written specifically for the April 2026 landscape — when the window is actually opening.
Word-for-word scripts for raising ketamine, psilocybin, MDMA, and ibogaine with your doctor, psychiatrist, or VA provider. Includes responses to 8 common objections.
Reviews of Mindbloom, Innerwell, Nue Life, Joyous, and more — with a comparison table, 5-question decision framework, red flags to avoid, and what's coming as psilocybin approaches FDA approval.
All files are instant PDF downloads — no account, no subscription, no waiting. Yours to keep.
🔒 Secure checkout · Instant delivery · 30-day money-back guarantee · No subscription
This guide was written by a board-certified clinician with clinical training in internal medicine — someone with direct access to the primary literature and a commitment to translating it honestly.
The public conversation around psychedelic medicine is full of hype, ideology, and incomplete information. This guide was written to close that gap — giving readers what they actually need to make informed decisions.
No agenda. No product to sell you next. Just what the data actually shows.
"I've spent years trying to find something that made sense of my treatment-resistant depression. This book didn't just give me information — it gave me a framework for asking the right questions. I walked into my psychiatrist's appointment with a completely different level of confidence."
"My son is a veteran. I've watched him struggle for eight years. This is the clearest, most honest thing I've read on ibogaine — it didn't oversell it, but it also didn't dismiss it. The veteran's guide alone was worth every penny."
"As someone who works in healthcare, I've been looking for something I could actually hand to patients. This is it. Rigorous enough to be credible, readable enough to be useful. The author clearly knows this literature."
If you read the ebook and don't find it valuable, email within 30 days for a full refund. No hoops, no explanations required. You keep the files either way — consider it a gift for giving it a shot.
This is the guide that closes that gap. Written by a clinician, grounded in the primary literature, built for people who are done with hype and ready for substance.